Posted inFDI
Biopharma SHAKTI: Why ₹10,000 Crore Is a Big FDI Signal
India’s pharmaceutical industry spent the last three decades churning out cheap generic pills for the world. We got incredibly good at manufacturing blister packs of paracetamol. It was profitable, sure. …
